For healthcare and wellness providers, understanding the difference between sterile and non-sterile compounded preparations is critical to patient safety, regulatory compliance, and clinical outcomes. From
Health systems, med spas, and specialty clinics increasingly rely on 503B outsourcing facilities to stabilize supply, standardize quality, and alleviate in-house sterile compounding risk. But
Personalized medicine is revolutionizing healthcare by moving beyond one-size-fits-all treatments toward tailored therapies designed around each patient’s unique biology, lifestyle, and treatment responses. This shift
Compounding pharmacies operating under Section 503B play a critical role in the pharmaceutical supply chain, producing sterile medications at scale while meeting stringent regulatory standards.
Compounding pharmacies operating under Section 503B play a critical role in the pharmaceutical supply chain, producing sterile medications at scale while meeting stringent regulatory standards.
ProRx Pharma is FDA registered as a 503b outsourcing facility operating under Current Good Manufacturing Practice standards and FDA oversight. We also maintain DEA registration
From controlled cleanroom environments to clearly defined systems and fully documented procedures, every step of our operation is structured to ensure consistency, safety, and reliability.
From formulation through final release, nothing is improvised—every step follows a defined regulatory framework. The result? Consistency. Traceability. Confidence. Watch Video >
Longevity medicine is increasingly being incorporated into structured, physician-directed care. Patients are no longer satisfied to simply extend their lifespans; they want to maximize their
We provide both sterile and non-sterile compounded preparations for clinics, telemedicine providers, wellness practices, and med spas nationwide—delivered with consistency, precision, and accountability at every
